NYSEAMERICAN:MYOMyomo Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Myomo Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.76 -0.02 (-0.53 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$3.63Now: $3.76▼$3.7850-Day Range N/A52-Week Range$2.82Now: $3.76▼$40.00Volume94,140 shsAverage Volume580,380 shsMarket Capitalization$10.58 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingMyomo has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.50, Myomo has a potential upside of 126.1% from its current price of $3.76.Amount of Analyst CoverageMyomo has only been the subject of 2 research reports in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesMyomo has received 149 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMyomo has received 132 “underperform” votes. (Add your “underperform” vote.)Community SentimentMyomo has received 53.02% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Myomo and other stocks. Vote “Outperform” if you believe MYO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MYO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMyomo does not currently pay a dividend.Dividend GrowthMyomo does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Myomo insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.21 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:MYO Previous Symbol CUSIPN/A CIK1369290 Webmyomo.com Phone+1-617-9969058Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees45 Outstanding Shares2,814,000Market Cap$10.58 million Next Earnings Date8/13/2020 (Estimated) OptionableNot Optionable AMEX:MYO Rates by TradingView Receive MYO News and Ratings via Email Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter. Myomo (NYSEAMERICAN:MYO) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Myomo? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Myomo. When is Myomo's next earnings date? Myomo is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Myomo. How were Myomo's earnings last quarter? Myomo Inc (NYSEAMERICAN:MYO) posted its quarterly earnings data on Thursday, May, 14th. The company reported ($2.51) EPS for the quarter, missing the Zacks' consensus estimate of ($2.06) by $0.45. The company had revenue of $1.01 million for the quarter, compared to analyst estimates of $0.78 million. View Myomo's earnings history. What price target have analysts set for MYO? 3 brokers have issued 12 month price objectives for Myomo's shares. Their forecasts range from $2.00 to $15.00. On average, they anticipate Myomo's share price to reach $8.50 in the next year. This suggests a possible upside of 126.1% from the stock's current price. View analysts' price targets for Myomo. Has Myomo been receiving favorable news coverage? Media headlines about MYO stock have been trending very negative recently, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Myomo earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news aboutMyomo. Are investors shorting Myomo? Myomo saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 63,700 shares, an increase of 226.7% from the April 15th total of 19,500 shares. Based on an average daily trading volume, of 720,100 shares, the short-interest ratio is presently 0.1 days. Approximately 2.3% of the shares of the stock are sold short. View Myomo's Current Options Chain. Who are some of Myomo's key competitors? Some companies that are related to Myomo include Protech Home Medical (PHM), MRI Interventions (CLPT), Polarean Imaging (POLX), Respiri (RSH), Anteo Diagnostics (ADO), Universal Biosensors (UBI), Helius Medical Technologies (HSM), Oventus Medical (OVN), LBT Innovations (LBT), Impedimed (IPD), Titan Medical (TMD), Inspiration Healthcare Group (IHC), Azure Healthcare (AZV), Heramed (HMD) and Analytica (ALT). View all competitors. What other stocks do shareholders of Myomo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Myomo investors own include Genocea Biosciences (GNCA), Remark (MARK), Protalix Biotherapeutics (PLX), Synergy Pharmaceuticals (SGYP), Sarepta Therapeutics (SRPT), Agile Therapeutics (AGRX), Anavex Life Sciences (AVXL), Ring Energy (REI), Ring Energy (REI) and Roku (ROKU). Who are Myomo's key executives? Myomo's management team includes the following people: Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 64)Mr. Jonathan Naft, VP & GM (Age 54)Mr. David A. Henry, Chief Financial Officer (Age 58)Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 69)Dr. Brandon Green DO, BOCP, Chief Medical Officer (Age 72) What is Myomo's stock symbol? Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO." Who are Myomo's major shareholders? Myomo's stock is owned by a variety of institutional and retail investors. Top institutional investors include ICM Asset Management Inc. WA (4.58%) and Sabby Management LLC (1.83%). Company insiders that own Myomo stock include David A Henry and Paul R Gudonis. View institutional ownership trends for Myomo. Which institutional investors are selling Myomo stock? MYO stock was sold by a variety of institutional investors in the last quarter, including ICM Asset Management Inc. WA. View insider buying and selling activity for Myomo. Which institutional investors are buying Myomo stock? MYO stock was bought by a variety of institutional investors in the last quarter, including Sabby Management LLC. Company insiders that have bought Myomo stock in the last two years include David A Henry, and Paul R Gudonis. View insider buying and selling activity for Myomo. How do I buy shares of Myomo? Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Myomo's stock price today? One share of MYO stock can currently be purchased for approximately $3.76. How big of a company is Myomo? Myomo has a market capitalization of $10.58 million. Myomo employs 45 workers across the globe. What is Myomo's official website? The official website for Myomo is myomo.com. How can I contact Myomo? Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company can be reached via phone at +1-617-9969058. This page was last updated on 5/29/2020 by MarketBeat.com Staff
